Development Co.

Development Co. is a specialized biotechnology firm focused on the early-stage development and optimization of therapeutic candidates across various modalities. The company operates primarily by identifying high-potential assets from academic and smaller research institutions and advancing them through the pre-clinical and IND-enabling stages. Their current portfolio emphasizes oncology and rare disease indications, utilizing a lean operational model to maximize development efficiency. By bridging the gap between discovery and clinical proof-of-concept, Development Co. aims to create value for partners and investors through strategic licensing and co-development agreements.